Constrained surfaces: promising therapeutic targets for COVID-19 determined by systematically mutational analysis

Signal Transduct Target Ther. 2021 Jan 29;6(1):38. doi: 10.1038/s41392-021-00469-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents* / therapeutic use
  • COVID-19*
  • Humans
  • Peptidyl-Dipeptidase A
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Peptidyl-Dipeptidase A